HIMS
NYSEHims & Hers Health, Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 29 recent filings. 28 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
WELLS DAVID B Director | Option exercise | 3.66K | — | — | 2026-06-11 |
WELLS DAVID B Director | Option exercise | 957 | — | — | 2026-06-15 |
WELLS DAVID B Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
WELLS DAVID B Director | Option exercise | 957 | $0.00 | — | 2026-06-15 |
Schultz Kare Director | Option exercise | 3.66K | — | — | 2026-06-11 |
Schultz Kare Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Perez Garcia Andrea G Director | Option exercise | 3.66K | — | — | 2026-06-11 |
Perez Garcia Andrea G Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Carroll Patrick Harrison Chief Medical Officer | Option exercise | 3.66K | — | — | 2026-06-11 |
Carroll Patrick Harrison Chief Medical Officer | Option exercise | 435 | — | — | 2026-06-15 |
Carroll Patrick Harrison Chief Medical Officer | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Carroll Patrick Harrison Chief Medical Officer | Option exercise | 435 | $0.00 | — | 2026-06-15 |
Autor Deborah M. Director, Chief Policy Officer | Option exercise | 3.66K | — | — | 2026-06-11 |
Autor Deborah M. Director, Chief Policy Officer | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Payne Christopher D Director | Option exercise | 3.66K | — | — | 2026-06-11 |
Payne Christopher D Director | Option exercise | 10.04K | — | — | 2026-06-15 |
Payne Christopher D Director | Option exercise | 647 | — | — | 2026-06-15 |
Payne Christopher D Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Payne Christopher D Director | Option exercise | 10.04K | $0.00 | — | 2026-06-15 |
Payne Christopher D Director | Option exercise | 647 | $0.00 | — | 2026-06-15 |
Pendarvis Christiane Director | Option exercise | 3.66K | — | — | 2026-06-11 |
Pendarvis Christiane Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Manuel Anja Director | Option exercise | 3.66K | — | — | 2026-06-11 |
Manuel Anja Director | Option exercise | 10.04K | — | — | 2026-06-15 |
Manuel Anja Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
Manuel Anja Director | Option exercise | 10.04K | $0.00 | — | 2026-06-15 |
Cosgrove Delos M. Director | Option exercise | 3.66K | — | — | 2026-06-11 |
Cosgrove Delos M. Director | Option exercise | 3.66K | $0.00 | — | 2026-06-11 |
WELLS DAVID B Director | Buy (open market) | 48.4K | $24.24 | $1,172,974.00 | 2026-05-26 |
Source: SEC EDGAR Forms 4/4A (CIK 1773751). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
🚀 $HIMS Might Be One of the Most Underrated Growth Stocks Right Now! Strong momentum, expanding opportunities, and a business model that continues to impress. 📈 I break down why I'm so bullish on $HIMS and what could drive the next leg higher. https://www.youtube.com/watch?v=fqDFpTuDlxM
$HIMS $40 next, then $60, no matter what!
$HIMS my guess is they do everything they possibly can to get this to tank this morning to exit their short.
$HIMS
$HIMS It wants more up. Cross the 200 SMA please 🫡
@ForkMAN @TD123 okay, so why wouldn’t I just buy my peptides from $HIMS ? After that July meeting, if it goes well, both of them will be able to sell a variety of peptides. Why wouldn’t I choose $HIMS? $HIMS Has a foothold in the telehealth business, they’re more established and been around longer. The only thing unique about $ENHA is the games, which personally I found very cool, however they don’t generate a ton of money and it only happens once a year All I’m saying is that need a better marketing plan, and not rely on reposting the same clips from the first games, it’s getting old fast.
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030 $HIMS https://stocktwits.com/news/equity/markets/hims-bull-peptides-19b-annual-revenue-2030/cZKWhQIR7EO
$HIMS $36 tomorrow, $42.69 by Thursday
$HIMS 🚀🚀🚀
$HIMS 🚀🚀🚀🚀🚀
@PaPaBaZi @LetsGoMets107 @mhparvez @blancoBull I've been shorting all long-term stocks in another account as a hedge, even though they will go up in the long term. You can short $HIMS in July 10th when you short SPY / QQQ - that one will swing violently. OPEN and GRAB are unlikely to go lower. My most favorite $AMTM is leveling but might dip to the high teens. FIG is leveling. DLO cannot reach below 8. TOST can go to the high teens. EOSE base is 5. In the long run, even if this year is not the year for these 8 picks, holding long term will be immensely rewarding -- for the overall portfolio.
$HIMS I heard they are starting a strategic crypto reserve! 😂
Latest news
3 Market-Beating Stocks with Exciting Potential
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030
Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds
Why Hims & Hers Health (HIMS) Is Up 11.0% After GLP-1 Weight Loss Pivot And Telehealth Deal
Analyst Report: Hims & Hers Health, Inc.
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout?
Fuel Up Your Portfolio with Suja Life’s Farm-to-Bottle Growth Strategy
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
The GLP-1 stock nobody is pricing in isn’t a drugmaker
Hims And Hers Expands Benefits As Investors Weigh Overvaluation And Volatility
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.